Stay updated on Tagraxofusp in CD123+ AML Clinical Trial
Sign up to get notified when there's something new on the Tagraxofusp in CD123+ AML Clinical Trial page.

Latest updates to the Tagraxofusp in CD123+ AML Clinical Trial page
- Check6 days agoChange DetectedThe displayed site revision changes from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check13 days agoChange DetectedThe site revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedA new revision entry v3.7.0 was added to the record history, indicating an updated version of the study record. The older revision v3.6.6 was removed from the visible history.SummaryDifference0.1%

- Check55 days agoChange DetectedThe study record history adds a new revision label v3.6.6 and removes the previous label v3.6.5. This reflects an update to the page's versioning history without altering the underlying content.SummaryDifference0.1%

- Check77 days agoChange DetectedA new revision entry for v3.6.5 was added to the record history, and the previous v3.6.4 entry was removed. This reflects an update to the study record metadata in the history log.SummaryDifference0.1%

- Check91 days agoChange DetectedAdded a new revision entry v3.6.4 and removed the previous revision v3.6.3 in the record history. This reflects an update to the study record versions on the page.SummaryDifference0.1%

Stay in the know with updates to Tagraxofusp in CD123+ AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tagraxofusp in CD123+ AML Clinical Trial page.